다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

XOMAP

XOMA (XOMAP)

XOMA Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:XOMAP

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/14	05:31	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:XOMAP	XOMA Corporation
2024/06/12	20:30	GlobeNewswire Inc.	XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher	NASDAQ:XOMAP	XOMA Corporation
2024/05/31	05:43	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XOMAP	XOMA Corporation
2024/05/18	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XOMAP	XOMA Corporation
2024/05/18	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XOMAP	XOMA Corporation
2024/05/18	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XOMAP	XOMA Corporation
2024/05/18	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XOMAP	XOMA Corporation
2024/05/18	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XOMAP	XOMA Corporation
2024/05/18	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XOMAP	XOMA Corporation
2024/05/16	20:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XOMAP	XOMA Corporation
2024/05/14	20:30	GlobeNewswire Inc.	XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ	NASDAQ:XOMAP	XOMA Corporation
2024/05/09	20:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XOMAP	XOMA Corporation
2024/05/09	20:35	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:XOMAP	XOMA Corporation
2024/05/09	20:30	GlobeNewswire Inc.	XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities	NASDAQ:XOMAP	XOMA Corporation
2024/04/30	20:30	GlobeNewswire Inc.	XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%	NASDAQ:XOMAP	XOMA Corporation
2024/04/25	20:30	GlobeNewswire Inc.	XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)	NASDAQ:XOMAP	XOMA Corporation
2024/04/03	22:00	GlobeNewswire Inc.	XOMA Corporation Announces Closing of Tender Offer	NASDAQ:XOMAP	XOMA Corporation
2024/03/21	20:30	GlobeNewswire Inc.	XOMA Declares Quarterly Preferred Stock Dividends	NASDAQ:XOMAP	XOMA Corporation
2024/03/20	05:05	GlobeNewswire Inc.	XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.	NASDAQ:XOMAP	XOMA Corporation
2024/03/11	19:56	Edgar (US Regulatory)	Form S-4 - Registration of securities, business combinations	NASDAQ:XOMAP	XOMA Corporation
2024/03/09	06:34	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:XOMAP	XOMA Corporation
2024/03/08	21:39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XOMAP	XOMA Corporation
2024/03/08	21:30	GlobeNewswire Inc.	XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value	NASDAQ:XOMAP	XOMA Corporation
2024/03/05	07:24	Edgar (US Regulatory)	Form SC TO-T - Tender offer statement by Third Party	NASDAQ:XOMAP	XOMA Corporation
2024/02/28	21:30	GlobeNewswire Inc.	XOMA to Present at Upcoming Investor Conferences in March	NASDAQ:XOMAP	XOMA Corporation
2024/02/16	23:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XOMAP	XOMA Corporation
2024/02/16	22:00	GlobeNewswire Inc.	XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right	NASDAQ:XOMAP	XOMA Corporation
2024/01/18	22:30	GlobeNewswire Inc.	XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition	NASDAQ:XOMAP	XOMA Corporation
2024/01/17	07:22	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:XOMAP	XOMA Corporation
2024/01/12	06:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XOMAP	XOMA Corporation

검색 관련기사 보기:NASDAQ:XOMAP

1 2 3 4 5 다음 >>

Deutsche Telekom (QX)

Energy Select Sector SPDR

American Express

Health Care Select Sector

US Dollar vs Sterling

Bank of America

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관